46P Prognostic impact of immune checkpoint inhibition in patients with metastatic non-small cell lung cancer (NSCLC): Real-world study in central Switzerland
Title:
46P Prognostic impact of immune checkpoint inhibition in patients with metastatic non-small cell lung cancer (NSCLC): Real-world study in central Switzerland
Author:
Allmann, V. Gautschi, O. Lehnick, D. Dyntar, D. Schwegler, C. Dressler, M. Godau, J. Niederberger, P. Zeidler, K. Diebold, J.